Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations.


Journal

Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 27 10 2022
received: 05 09 2022
accepted: 31 10 2022
pubmed: 21 11 2022
medline: 3 3 2023
entrez: 20 11 2022
Statut: ppublish

Résumé

As dual EGFR and VEGFR-2 inhibitors, 22 innovative thiazolidine-2,4-diones were modeled, constructed, and measured for their anticancer performance versus four human neoplasms HCT-116, MCF-7, A549, and HepG2. Molecular docking and MD simulation were performed to inspect the binding technique of the proffered congeners with the EGFR and VEGFR-2 receptors. Evidence realized thanks to the docking inquests was vastly consistent together with that detected through the biological screening. Structures 14a and 14g emerged as the most active compounds toward HCT116 (IC

Identifiants

pubmed: 36403198
doi: 10.1002/ardp.202200465
doi:

Substances chimiques

Sorafenib 9ZOQ3TZI87
Erlotinib Hydrochloride DA87705X9K
ErbB Receptors EC 2.7.10.1
Antineoplastic Agents 0
Thiazolidines 0
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1
Tyrosine Kinase Inhibitors 0
Protein Kinase Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200465

Informations de copyright

© 2022 Deutsche Pharmazeutische Gesellschaft.

Références

D. Panigrahy, S. Singer, L. Q. Shen, C. E. Butterfield, D. A. Freedman, E. J. Chen, M. A. Moses, S. Kilroy, S. Duensing, C. Fletcher, J. A. Fletcher, L. Hlatky, P. Hahnfeldt, J. Folkman, A. Kaipainen, J. Clin. Invest. 2002, 110(7), 923. https://doi.org/10.1172/JCI15634
H. Joshi, T. Pal, C. Ramaa, Expert Opin. Invest. Drugs 2014, 23(4), 501. https://doi.org/10.1517/13543784.2014.884708
U. Bhanushali, S. Rajendran, K. Sarma, P. Kulkarni, K. Chatti, S. Chatterjee, C. S. Ramaa, Bioorg. Chem. 2016, 67, 139. https://doi.org/10.1016/j.bioorg.2016.06.006
E. S. Ch'ng, H. Jaafar, S. E. Tuan Sharif, Patholog. Res. Int. 2011, 2011, 1. https://doi.org/10.4061/2011/572706
X. Le, M. Nilsson, J. Goldman, M. Reck, K. Nakagawa, T. Kato, L. P. Ares, B. Frimodt-Moller, K. Wolff, C. Visseren-Grul, J. V. Heymach, E. B. Garon, J. Thorac. Oncol. 2021, 16(2), 205. https://doi.org/10.1016/j.jtho.2020.10.006
A. Midha, S. Dearden, R. McCormack, Am. J. Cancer Res. 2015, 5, 2892.
P. A. Jänne, J. C. H. Yang, D. W. Kim, D. Planchard, Y. Ohe, S. S. Ramalingam, M.-J. Ahn, S.-W. Kim, W.-C. Su, L. Horn, D. Haggstrom, E. Felip, J.-H. Kim, P. Frewer, M. Cantarini, K. H. Brown, P. A. Dickinson, S. Ghiorghiu, M. Ranson, N. Engl. J. Med. 2015, 372, 1689.
J. J. Lin, S. Cardarella, C. A. Lydon, S. E. Dahlberg, D. M. Jackman, P. A. Jänne, B. E. Johnson, J. Thorac. Oncol. 2016, 11, 556. https://doi.org/10.1016/j.jtho.2015.12.103
A. K. Larsen, D. Ouaret, K. El Ouadrani, A. Petitprez, Pharmacol. Ther. 2011, 131, 80. https://doi.org/10.1016/j.pharmthera.2011.03.012
M. N. Balak, Y. Gong, G. J. Riely, R. Somwar, A. R. Li, M. F. Zakowski, A. Chiang, G. Yang, O. Ouerfelli, M. G. Kris, M. Ladanyi, V. A. Miller, W. Pao, Clin. Cancer Res. 2006, 12(21), 6494. https://doi.org/10.1158/1078-0432.CCR-06-1570
T. Kosaka, Y. Yatabe, H. Endoh, K. Yoshida, T. Hida, M. Tsuboi, H. Tada, H. Kuwano, T. Mitsudomi, Clin. Cancer Res. 2006, 12(19), 5764. https://doi.org/10.1158/1078-0432.CCR-06-0714
K. Suda, R. Onozato, Y. Yatabe, T. Mitsudomi, J. Thorac. Oncol. 2009, 4(1), 1. https://doi.org/10.1097/JTO.0b013e3181913c9f
P. M. Hoff, K. K. Machado, Cancer Treat. Rev. 2012, 38(7), 825.
Z. K. Otrock, J. A. Makarem, A. I. Shamseddine, Blood. Cells Mol. Dis. 2007, 38(3), 258. https://doi.org/10.1016/j.bcmd.2006.12.003
E. S. Gershtein, E. A. Dubova, A. I. Shchegolev, N. E. Kushkinskii, Bull. Exp. Biol. Med. 2010, 149(6), 749. https://doi.org/10.1007/s10517-010-1043-8
D. K. Shah, K. M. J. Menon, L. M. Cabrera, A. Vahratian, S. K. Kavoussi, D. I. Lebovic, Fertil. Steril. 2010, 93(6), 2042. https://doi.org/10.1016/j.fertnstert.2009.02.059
S. Takahashi, Biol. Pharm. Bull. 2011, 34(12), 1785.
P. Wu, T. E. Nielsen, M. H. Clausen, Trends Pharmacol. Sci. 2015, 36(7), 422. https://doi.org/10.1016/j.tips.2015.04.005
T. Francis, S. R. Dixit, B. R. P. Kumar, Polycyclic Aromat. Compd. 2020, 42(5). https://doi.org/10.1080/10406638.2020.1836004
Y. Chen, J. Wu, A. Wang, Z. Qi, T. Jiang, C. Chen, F. Zou, C. Hu, W. Wang, H. Wu, Z. Hu, W. Wang, B. Wang, L. Wang, T. Ren, S. Zhang, Q. Liu, J. Liu, Eur. J. Med. Chem. 2017, 139, 674. https://doi.org/10.1016/j.ejmech.2017.08.035
J. Chang, H. Ren, M. Zhao, Y. Chong, W. Zhao, Y. He, Y. Zhao, H. Zhang, C. Qi, Eur. J. Med. Chem. 2017, 138, 669. https://doi.org/10.1016/j.ejmech.2017.07.005
Y. A. M. M. Elshaier, M. A. Shaaban, M. K. Abd El Hamid, M. H. Abdelrahman, M. A. Abou-Salim, S. M. Elgazwi, F. Halaweish, Bioorg. Med. Chem. 2017, 25(12), 2956. https://doi.org/10.1016/j.bmc.2017.03.002
H.-Q. Zhang, F.-H. Gong, J.-Q. Ye, C. Zhang, X.-H. Yue, C.-G. Li, Y.-G. Xu, L.-P. Sun, Eur. J. Med. Chem. 2017, 125, 245.
M. L. C. Barbosa, L. M. Lima, R. Tesch, C. M. R. Sant'Anna, F. Totzke, M. H. G. Kubbutat, C. Schächtele, S. A. Laufer, E. J. Barreiro, Eur. J. Med. Chem. 2014, 71, 1.
A. Garofalo, L. Goossens, A. Lemoine, S. Ravez, P. Six, M. Howsam, A. Farce, P. Depreux, Med. Chem. Commun. 2011, 2, 65.
K. El-Adl, A. A. Abdel-Rahman, A. M. Omar, M. Alswah, N. M. Saleh, Arch. Pharm. (Weinheim) 2021, 355, e2100237. https://doi.org/10.1002/ardp.202100237
V. Gandin, A. Ferrarese, M. Dalla Via, C. Marzano, A. Chilin, G. Marzaro, Sci. Rep. 2015, 5, 16750.
K. El-Adl, H. Sakr, M. Nasser, M. Alswah, F. Shoman, Arch. Pharm. (Weinheim) 2020, 353, e2000079. https://doi.org/10.1002/ardp.202000079
K. El-Adl, A. G. A. El-Helby, H. Sakr, S. S. A. El-Hddad, Arch. Pharm. (Weinheim) 2020, 353, e2000068. https://doi.org/10.1002/ardp.202000068
K. El-Adl, A. A. El-Helby, H. Sakr, I. H. Eissa, S. S. A. El-Hddad, F. M. A. Shoman, Bioorg. Chem. 2020, 102. https://doi.org/10.1016/j.bioorg.2020.104059.
A. M. Sayed, F. A. Taher, M. R. K. Abdel-Samad, M. S. A. El-Gaby, K. El-Adl, N. M. Saleh, Bioorg. Chem. 2021, 108, 104669. https://doi.org/10.1016/j.bioorg.2021.104669.
N. M. Saleh, M. El-Gaby, K. El-Adl, N. Abd El-Sattar, Bioorg. Chem. 2020, 104, 104350. https://doi.org/10.1016/j.bioorg.2020.104350
K. El-Adl, A. G. A. El-Helby, H. Sakr, A. Elwan, Bioorg. Chem. 2020, 105, 104399. https://doi.org/10.1016/j.bioorg.2020.104399.
K. El-Adl, A. G. A. El-Helby, H. Sakr, A. Elwan, New J. Chem. 2021, 45, 881. https://doi.org/10.1039/D0NJ02990D
N. E. A. Abd El-Sattar, K. El-Adl, M. A. El-Hashash, S. A. Salama, M. M. Elhady, Bioorg. Chem. 2021, 22(115), 105186. https://doi.org/10.1016/j.bioorg.2021.105186.
N. A. A. M. Aziz, R. F. George, K. El-Adl, W. R. Mahmoud, RSC Adv. 2022, 12, 12913. https://doi.org/10.1039/d2ra01119k
Q.-Q. Xie, H. Z. Xie, J. X. Ren, L. L. Li, S. Y. Yang, J. Mol. Graph. Model. 2009, 27(6), 751. https://doi.org/10.1016/j.jmgm.2008.11.008
K. Lee, K. W. Jeong, Y. Lee, J. Y. Song, M. S. Kim, G. S. Lee, Y. Kim, Eur. J. Med. Chem. 2010, 45(11), 5420. https://doi.org/10.1016/j.ejmech.2010.09.002
V. A. Machado, D. Peixoto, R. Costa, H. J. C. Froufe, R. C. Calhelha, R. M. V. Abreu, I. C. F. R. Ferreira, R. Soares, M. Queiroz, Bioorg. Med. Chem. 2015, 23(19), 6497.
Z. Wang, N. Wang, S. Han, D. Wang, S. Mo, L. Yu, H. Huang, K. Tsui, J. Shen, J. Chen, PLoS One 2013, 8(7), e68566. https://doi.org/10.1371/journal.pone.0068566
J. Dietrich, C. Hulme, L. H. Hurley, Bioorg. Med. Chem. 2010, 18(15), 5738. https://doi.org/10.1016/j.bmc.2010.05.063
Z. Zhao, H. Wu, L. Wang, Y. Liu, S. Knapp, Q. Liu, N. S. Gray, ACS Chem. Biol. 2014, 9(6), 1230.
S. A. Elmetwally, K. F. Saied, I. H. Eissa, E. B. Elkaeed, Bioorg. Chem. 2019, 88, 102944. https://doi.org/10.1016/j.bioorg.2019.102944
F. M. F. Chen, N. L. Benoiton, Can. J. Chem. 1987, 65(3), 619.
J. Maru, J. Curr. Chem. Pharm. Sci. 2014, 4(4), 164.
F. Khedr, M.-K. Ibrahim, I. H. Eissa, H. S. Abulkhair, K. El-Adl, Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201
T. Mosmann, J. Immunol. Methods 1983, 65(1-2), 55. https://doi.org/10.1016/0022-1759(83)90303-4
J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman, D. A. Case, J. Comput. Chem. 2004, 25(9), 1157.
A. Beig, R. Agbaria, A. Dahan, PLoS One 2013, 8, e68237. https://doi.org/10.1371/journal.pone.0068237
J. A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K. E. Hauser, C. Simmerling, J. Chem. Theory Comput. 2015, 11(8), 3696.
F. M. Freimoser, C. A. Jakob, M. Aebi, U. Tuor, Appl. Environ. Microbiol. 1999, 65(8), 3727.
S. M. Abou-Seri, W. M. Eldehna, M. M. Ali, D. A. Abou El Ella, Eur. J. Med. Chem. 2016, 107, 165.
Y. Jia, C. M. Quinn, A. I. Gagnon, R. Talanian, Anal. Biochem. 2006, 356(2), 273.
C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Deliv. Rev. 1997, 23, 3. https://doi.org/10.1016/S0169-409X(96)00423-1
D. E. V. Pires, T. L. Blundell, D. B. Ascher, J. Med. Chem. 2015, 58, 4066. https://doi.org/10.1021/acs.jmedchem.5b00104

Auteurs

Nada A A M Aziz (NAAM)

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt.

Riham F George (RF)

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Khaled El-Adl (K)

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, Egypt.
Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.

Walaa R Mahmoud (WR)

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH